Algernon Pharmaceuticals has received FDA approval to study DMT for use in stroke patients to help rebuild synaptic connections.
https://psychedelicspotlight.com/wp-content/uploads/2021/05/synapse-psychedelic-spotlight.jpg6671000Jennifer Walker-Journeyhttps://psychedelicspotlight.com/wp-content/uploads/2023/01/PS_LOGO_PRIMARY_DOT_WHT-1.pngJennifer Walker-Journey2021-05-18 18:08:062021-05-18 18:08:06Algernon to Become the First Company in the World to Study DMT for Stroke Patients
Get a roundup of Psychedelic news stories in your inbox
By signing up to the Psychedelic Spotlight newsletter you agree to receive electronic communications from Psychedelic Spotlight that may sometimes include advertisements or sponsored content.